Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIMO: Xeomin for Spasticity in Children with Cerebral Palsy
NCT01905683Phase 3Completed
- Sponsor
- Merz
- Start
- Aug 2013
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of incobotulinumtoxinA in spasticity, sponsored by Merz. Started Aug 2013; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01905683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905683.